Yorktown Management & Research CO Inc Exact Sciences Corp Transaction History

Yorktown Management & Research CO Inc

  • $93.2 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 04, 2022
BUY
$31.97 - $49.37 $203,329 - $313,993
6,360 New
6,360 $207,000
Q4 2021

Feb 09, 2022
SELL
$72.5 - $100.68 $176,900 - $245,659
-2,440 Closed
0 $0
Q3 2021

Nov 04, 2021
BUY
$90.24 - $124.05 $220,185 - $302,682
2,440 New
2,440 $233,000

Others Institutions Holding EXAS

# of Institutions
673
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Yorktown Management & Research CO Inc Portfolio

Follow Yorktown Management & Research CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yorktown Management & Research CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Yorktown Management & Research CO Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email